Exploration of Recombinant Fusion Proteins YAPO and YAPL as Carrier Proteins for Glycoconjugate Vaccine Design against Streptococcus pneumoniae Infection.

ACS Infectious Diseases
Shaojie FengGuofeng Gu

Abstract

Pneumolysin (Ply), pneumococcal surface protein A (PspA), and pneumococcal surface adhesin A (PsaA) are promising cell surface protein antigen targets for Streptococcus pneumoniae (Spn) vaccine development. Herein, we designed and recombined two fusion proteins, named YAPO and YAPL, which contained the main antigenic epitopes of Ply, PspA, and PsaA. In-depth immunological evaluations revealed that YAPO and YAPL had strong immunocompetence to be well-qualified potential carrier proteins. To verify this possibility, a serotype 3 Spn (ST3) CPS pentasaccharide was conjugated to each fusion protein to generate the resultant glycoconjugates. Immunological studies in mice revealed that, as compared with TT conjugate, YAPO and YAPL conjugates provoked robust T-cell dependent immune responses that could provide better recognition, in vitro efficient opsonophagocytosis, and in vivo effective protection against various serotypes of Spn. Collectively, YAPO and YAPL were identified as immunopotentiating carriers that could help convert immunologically inactive ST3 pentasaccharide into a T cell-dependent antigen and provide efficient and broad spectrum of immunoprotection coverage so as to formulate functional glycoconjugate vaccines against...Continue Reading

References

Jan 1, 1991·Annual Review of Immunology·J V Ravetch, J P Kinet
Jul 2, 2003·The Journal of Biological Chemistry·Shenhui Lang, Michael Palmer
Sep 17, 2005·Pharmacotherapy·Angela E Bridy-PappasDaniel J Isaacman
Dec 3, 2005·Science·Falk Nimmerjahn, Jeffrey V Ravetch
Feb 10, 2006·Clinical and Vaccine Immunology : CVI·Sandra Romero-SteinerMoon H Nahm
Dec 28, 2007·Vaccine·Africa González-FernándezCarmen Fernández
Aug 30, 2008·Critical Reviews in Microbiology·Gowrisankar RajamEdwin W Ades
Jul 6, 2010·Vaccine·Ron DaganClaire-Anne Siegrist
Oct 30, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Reshmi MukerjiDavid E Briles
Dec 20, 2012·Chemical Society Reviews·Francesco Peri
Jul 31, 2013·Critical Reviews in Microbiology·Michelle DarrieuxLuciana Cezar de Cerqueira Leite
Sep 10, 2014·Journal of Molecular Microbiology and Biotechnology·Shirin Tarahomjoo
Oct 6, 2014·Nature Chemical Biology·Regan J AndersonIan F Hermans
Nov 6, 2015·Human Vaccines & Immunotherapeutics·Michael E PichicheroQingfu Xu
Dec 1, 2015·Human Vaccines & Immunotherapeutics·H Findlow, R Borrow
Nov 8, 2016·Cell Chemical Biology·Sharavathi Guddehalli ParameswarappaPeter H Seeberger
Feb 6, 2017·Vaccine·Vanessa T DevineStuart C Clarke
May 18, 2017·Frontiers in Microbiology·Naeem Khan, Arif T Jan
Aug 6, 2017·Pediatrics International : Official Journal of the Japan Pediatric Society·Hiroshi SakataUNKNOWN Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease
Nov 14, 2017·Expert Review of Vaccines·Michael E Pichichero
Apr 12, 2018·International Journal of Molecular Sciences·Ronald AndersonCharles Feldman
Jul 11, 2018·Frontiers in Immunology·Lavida R K Brooks, George I Mias
Dec 21, 2018·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Maruthi PrasannaCyrille Grandjean
Feb 3, 2019·The Lancet Infectious Diseases·Joseph A Lewnard, William P Hanage

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.